Related Experiment Video
Updated: Aug 6, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
Vitamin D in pulmonary disease
Emily M O'Reilly1,2, Desmond M Murphy1,2
1Department of Respiratory Medicine, Cork University Hospital, Cork, Ireland.
Vitamin D may impact respiratory health by influencing inflammation and immunity. More research, especially large trials in vitamin D deficient individuals, is needed to confirm its benefits for various lung conditions.
Area of Science:
- Pulmonary Medicine
- Immunology
- Nutritional Science
Background:
- Vitamin D is crucial for calcium and bone metabolism.
- Emerging evidence suggests vitamin D also modulates inflammation, immunity, and host defense.
- Vitamin D insufficiency is linked to adverse respiratory outcomes.
Purpose of the Study:
- To review the literature on vitamin D's role in inflammatory mechanisms of respiratory diseases.
- To explore vitamin D's immunomodulatory and anti-inflammatory effects in lung conditions.
- To assess the current evidence for vitamin D supplementation in respiratory disease.
Main Methods:
- Narrative review of existing literature.
- Focus on inflammatory pathways in asthma, COPD, interstitial lung disease, lung cancer, tuberculosis, and acute respiratory infections.
- Analysis of observational studies and clinical trial data.
Main Results:
- Vitamin D influences immune responses and inflammation relevant to respiratory health.
- Observational data often support a protective role for vitamin D.
- Clinical trial results are mixed and do not consistently align with mechanistic data.
Conclusions:
- The precise clinical utility of vitamin D supplementation for respiratory diseases remains unclear.
- Further large-scale, long-duration randomized controlled trials are necessary.
- Future studies should prioritize vitamin D-deficient populations to clarify its role.
Related Concept Videos
Role of Skin in Vitamin D Synthesis
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin D3(cholecalciferol).
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...